|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.59 USD | -0.55% |
|
-5.53% | -26.73% |
Adaptive Biotechnologies Corporation reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 37.65 million compared to USD 38.62 million a year ago. Net loss was USD 57.7 million compared to USD 62.74 million a year ago.
Basic loss per share from continuing operations was USD 0.4 compared to USD 0.44 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -26.73% | 532M | |
| -31.06% | 9.3B | |
| -8.43% | 3.1B | |
| +27.31% | 2.87B | |
| -14.31% | 2.17B | |
| -18.94% | 1.75B | |
| +73.13% | 1.5B | |
| +30.25% | 807M | |
| -1.97% | 759M | |
| +5.17% | 313M |
ADAPTIVE BIOTECHNOLOGIES CORPORATION 